ICON News

TD Cowen: Maintaining the Icon (ICLR.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $349.00 to $373.00.

Zhitong FinanceJun 1 01:30

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Celcuity (CELC) and Icon (ICLR)

TipRanksMay 31 20:20

ICON PLC: TD Cowen raises price target from $349 to $373

Zhitong FinanceMay 31 18:31

Barclays Sticks to Their Buy Rating for Icon (ICLR)

TipRanksMay 31 16:26

ICON PLC: J.P. Morgan raises price target from $375 to $385

Zhitong FinanceMay 31 11:12

Icon's Strategic Growth and Profitability Outlook Affirm Buy Rating

TipRanksMay 31 11:04

Buy Rating for Icon's Stock Maintained: Fiscal Optimism Driven by Debt Refinancing and Strong Market Position

TipRanksMay 31 00:05

Icon (ICLR) Receives a Buy From Truist Financial

TipRanksApr 29 19:52

TD Cowen: Maintaining the Icon (ICLR.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $343.00 to $349.00.

Zhitong FinanceApr 27 01:30

UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating

MT NewswiresApr 26 22:54

Barclays Remains a Buy on Icon (ICLR)

TipRanksApr 26 16:48

Buy Rating Affirmed for Icon Based on Strong Financials and Growth Potential

TipRanksApr 26 14:22

Truist Financial Reaffirms Their Buy Rating on Icon (ICLR)

TipRanksApr 25 19:10

Barclays Remains a Buy on Icon (ICLR)

TipRanksApr 10 14:48

Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Neurocrine (NBIX)

TipRanksApr 8 16:31

Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Icon (ICLR) and Teladoc (TDOC)

TipRanksApr 5 20:41

Icon Analyst Ratings

BenzingaApr 4 20:39

Mizuho Reiterates Buy on Icon, Maintains $346 Price Target

BenzingaApr 4 20:40

Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)

TipRanksApr 4 20:20

Mizuho Securities Ups Price Target on ICON to $346 From $315, Keeps Buy Rating

MT NewswiresFeb 23 23:58